Rb-loss is associated with high malignancy in chondrosarcoma

  • Authors:
    • M. Röpke
    • C. Boltze
    • B. Meyer
    • H. W. Neumann
    • A. Roessner
    • R. Schneider-Stock
  • View Affiliations

  • Published online on: January 1, 2006     https://doi.org/10.3892/or.15.1.89
  • Pages: 89-95
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Loss of function of the human retinoblastoma gene (Rb) is a frequent genetic abnormality in human malignancies and causes a disturbance in the cell cycle and loss of normal proliferation and differentiation. We studied the loss of heterozygosity (LOH) of the Rb gene in 31 formalin-fixed, paraffin-embedded cartilaginous tumors using polymerase chain reaction. The tumors were subdivided into 8 cases of dedifferentiated (DD) chondrosarcoma, 17 cases of conventional chondrosarcoma (nine grade 1, seven grade 2 and one grade 3), 4 enchondromas and 2 chondroblastomas. Both components of DD chondrosarcoma, the low-grade and anaplastic components, were separated by a microdissection approach. The genetic data were correlated with the expression of the Rb protein examined by Rb immunohistochemistry. We found Rb-LOH in one grade 3 chondrosarcoma, and in the anaplastic component in 7 of 8 cases of DD chondrosarcoma (89% of all high-grade chondrosarcomas). All tumors with Rb-LOH were immunohistochemically Rb-negative. The only case of DD chondrosarcoma negative for Rb-LOH in both components of the tumor also showed weak expression of the Rb protein in the anaplastic component. All benign cartilaginous tumors, low-grade chondrosarcomas and low-grade tumor components of DD chondrosarcomas were negative regarding Rb-LOH but positive in Rb immunohistostaining. We concluded that Rb-LOH predominantly occurs in high-grade chondrosarcomas. However, it is not a marker for identifying low-grade tumors with a tendency towards progression or local recurrence.

Related Articles

Journal Cover

January 2006
Volume 15 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Röpke M, Boltze C, Meyer B, Neumann HW, Roessner A and Schneider-Stock R: Rb-loss is associated with high malignancy in chondrosarcoma. Oncol Rep 15: 89-95, 2006
APA
Röpke, M., Boltze, C., Meyer, B., Neumann, H.W., Roessner, A., & Schneider-Stock, R. (2006). Rb-loss is associated with high malignancy in chondrosarcoma. Oncology Reports, 15, 89-95. https://doi.org/10.3892/or.15.1.89
MLA
Röpke, M., Boltze, C., Meyer, B., Neumann, H. W., Roessner, A., Schneider-Stock, R."Rb-loss is associated with high malignancy in chondrosarcoma". Oncology Reports 15.1 (2006): 89-95.
Chicago
Röpke, M., Boltze, C., Meyer, B., Neumann, H. W., Roessner, A., Schneider-Stock, R."Rb-loss is associated with high malignancy in chondrosarcoma". Oncology Reports 15, no. 1 (2006): 89-95. https://doi.org/10.3892/or.15.1.89